current unmet needs in itp: impaired quality of life & chronic disorders
Published 1 year ago • 296 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
2:03
unmet needs in immune thrombocytopenia
-
0:51
key unmet needs in the treatment of immune-mediated ttp
-
3:15
long-term risks associated with persistent isolated mild thrombocytopenia
-
3:40
current unmet needs in pv & et
-
3:17
thrombopoietin receptor agonists in itp: current status and future outlooks
-
1:06:04
itp: novel treatments
-
1:39:13
itp insights - living with itp: common itp questions
-
25:29
immune thrombocytopenia looking beyond the platelet count presented by dr cindy neunert
-
1:24
recent advances in the treatment and management of itp
-
1:54
fostamatinib and efgartigimod: novel agents in the treatment of itp
-
1:24
unmet needs in ttp
-
1:49
pid unmet needs: awareness, testing and diagnosis
-
1:28
differentiating immune thrombocytopenia from ipd and pid
-
2:38
the management of itp during and after the covid-19 pandemic
-
45:50
treating persistent/chronic itp current care, future potential
-
0:52
the role and clinical use of tpo receptor agonists in the treatment of itp
-
1:09
challenges associated with managing chemotherapy-induced thrombocytopenia
-
3:23
session overview: improving treatment for patients with itp
-
1:46
current treatment approaches in et and an insight into the surpass-et trial
-
2:06
persistent isolated mild thrombocytopenia: novel clinical guidance statement
-
0:57
bpdcn: unmet needs and challenges